# Spyre Therapeutics, Inc. (SYRE)

> Healthcare · US · Reports in USD

Fundamental indicators from Sponda, adjusted for inflation.

[HTML version](https://sponda.capital/en/SYRE/fundamentals)

## Annual figures

| Year | Revenue (M) | Net Inc. (M) | FCF (M) | Debt (M) | Equity (M) |
| --- | --- | --- | --- | --- | --- |
| 2026 | $ 0 | $ -105.21M | $ -127.25M | $ 0 | $ 1.10B |
| 2025 | $ 92.66M | $ -158.91M | $ -173.30M | $ 0 | $ 715.24M |
| 2024 | $ 0 | $ -218.64M | $ -165.45M | $ 0 | $ 517.80M |
| 2023 | $ 958.0K | $ -366.32M | $ -108.03M | $ 0 | $ 184.02M |
| 2022 | $ 2.60M | $ -93.63M | $ -89.57M | $ 4.63M | $ 50.31M |
| 2021 | $ 22.27M | $ -78.21M | $ -64.53M | $ 5.06M | $ 83.94M |
| 2020 | $ 0 | $ -103.05M | $ -101.98M | $ 5.45M | $ 139.83M |
| 2019 | $ 0 | $ -101.01M | $ -86.72M | $ 5.06M | $ 60.08M |
| 2018 | $ 5.13M | $ -58.57M | $ -43.07M | $ 0 | $ 67.43M |
| 2017 | $ 7.01M | $ -36.69M | $ -33.99M | $ 0 | $ 50.34M |
| 2016 | $ 6.37M | $ -29.85M | $ -26.21M | $ 0 | $ 62.97M |
| 2015 | $ 8.54M | $ -15.86M | $ -15.71M | $ 0 | $ 36.10M |
| 2014 | $ 0 | $ -14.62M | $ -10.62M | $ 0 | $ 1.87M |

Columns not available in this view: annualPriceMultiples, dividends. They require live market data and are shown on the HTML page instead.

## Leverage and liquidity

| Indicator | Value |
| --- | --- |
| Gross Debt / Eq | 0.00 |
| Liabilities / Eq | 0.07 |
| Current Ratio | 18.53 |

## Other views

- [Metrics](https://sponda.capital/en/SYRE.md)
- [Charts](https://sponda.capital/en/SYRE/charts.md)
- [Compare](https://sponda.capital/en/SYRE/compare.md)
- [Indicator definitions](https://sponda.capital/en/screener.md)

Data as of 2026-08-30.